- Home
- RVMD vs BRKR Comparison
RVMD vs BRKR Comparison
Compare RVMD & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVMD
- BRKR
- Stock Information
- Founded
- RVMD 2014
- BRKR 1960
- Country
- RVMD United States
- BRKR United States
- Employees
- RVMD N/A
- BRKR N/A
- Industry
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- RVMD Health Care
- BRKR Industrials
- Exchange
- RVMD Nasdaq
- BRKR Nasdaq
- Market Cap
- RVMD 7.5B
- BRKR 6.4B
- IPO Year
- RVMD 2020
- BRKR 2000
- Fundamental
- Price
- RVMD $38.11
- BRKR $43.94
- Analyst Decision
- RVMD Strong Buy
- BRKR Buy
- Analyst Count
- RVMD 12
- BRKR 12
- Target Price
- RVMD $68.67
- BRKR $54.50
- AVG Volume (30 Days)
- RVMD 3.3M
- BRKR 2.6M
- Earning Date
- RVMD 08-06-2025
- BRKR 08-05-2025
- Dividend Yield
- RVMD N/A
- BRKR 0.46%
- EPS Growth
- RVMD N/A
- BRKR N/A
- EPS
- RVMD N/A
- BRKR 0.52
- Revenue
- RVMD N/A
- BRKR $3,446,100,000.00
- Revenue This Year
- RVMD N/A
- BRKR $6.43
- Revenue Next Year
- RVMD $241.39
- BRKR $4.21
- P/E Ratio
- RVMD N/A
- BRKR $83.35
- Revenue Growth
- RVMD N/A
- BRKR 14.84
- 52 Week Low
- RVMD $29.17
- BRKR $34.10
- 52 Week High
- RVMD $62.40
- BRKR $72.94
- Technical
- Relative Strength Index (RSI)
- RVMD 47.77
- BRKR 65.43
- Support Level
- RVMD $36.37
- BRKR $41.01
- Resistance Level
- RVMD $38.97
- BRKR $44.80
- Average True Range (ATR)
- RVMD 1.50
- BRKR 1.77
- MACD
- RVMD 0.02
- BRKR 0.26
- Stochastic Oscillator
- RVMD 40.07
- BRKR 87.45
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.